Dossier
pulmonary arterial hypertension
Coverage of pulmonary arterial hypertension in the Nexus archive.
- New Drug Prevents Worsening Pulmonary Arterial Hypertension in Major Trial Win
Oral ralinepag may receive FDA approval after showing effectiveness in preventing worsening of pulmonary arterial hypertension in a phase III trial. The drug's success in the ADVANCE OUTCOMES trial could lead to its approval as a treatment for PAH.